Alnylam Pharmaceuticals, Inc.
MULTI-TARGETED SINGLE ENTITY CONJUGATES
Last updated:
Abstract:
The present invention relates, in general to, compounds, compositions and methods useful for modulating gene expression of multiple target nucleic acids by a single chemical entity.
Status:
Application
Type:
Utility
Filling date:
22 Feb 2021
Issue date:
7 Apr 2022